Science
Revolutionizing delivery
across the blood-brain barrier.
Our Platform: TRACER
Reaching CNS targets once thought unreachable.
Voyager’s TRACER™ (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) capsid discovery platform is a broadly applicable, RNA-based screening platform that enables rapid discovery of AAV capsids with robust penetration of the blood-brain barrier and enhanced central nervous system (CNS) tropism in multiple species, including non-human primates (NHPs).
Non-Viral Approaches
Multiple modalities to treat neurological diseases.
“I love how we all get to collaborate, even though we are on different teams.”

Recent Publications & Presentations
Molecular Therapy:
Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-brain barrier
ASGCT 2025:
Tuesday, May 13th
Wednesday, May 14th
Thursday, May 15th
Assessment of Two HEK293 Cell Line Cloning Strategies to Improve AAV Yield
Our Pipeline
Partnerships
Our allies in realizing the potential of neuro-genetic medicines


